Here's the live share price of Vivanza Biosciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Vivanza Biosciences has gained 2.76% CAGR. Over the past year, the corresponding return has been -46.15%.
Vivanza Biosciences’s current P/E of -9.86x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Vivanza Biosciences | 3.45 | 0.96 | -7.08 | -0.47 | -46.15 | -47.76 | 2.76 |
Sun Pharmaceutical Industries | 1.67 | -0.74 | -1.73 | -5.03 | -13.17 | 22.82 | 25.92 |
Divi's Laboratories | 0.43 | -1.79 | -7.35 | 6.82 | 11.03 | 18.72 | 13.53 |
Cipla | -0.28 | -0.33 | 3.71 | 4.44 | -6.69 | 14.64 | 15.70 |
Torrent Pharmaceuticals | -1.10 | -2.72 | 9.28 | 16.13 | 2.96 | 33.93 | 20.15 |
Dr. Reddy's Laboratories | 0.52 | 3.73 | -0.61 | 13.95 | -1.15 | 16.94 | 6.31 |
Mankind Pharma | -1.64 | 3.88 | 9.08 | 18.13 | 4.58 | 21.69 | 12.50 |
Zydus Lifesciences | -0.57 | 4.75 | 7.77 | 15.69 | -6.93 | 42.16 | 21.26 |
Lupin | 2.60 | 3.02 | 4.40 | 1.91 | -10.64 | 46.79 | 14.35 |
Abbott India | -0.85 | -4.90 | -2.43 | 2.84 | 7.47 | 21.30 | 13.54 |
Alkem Laboratories | 2.66 | 2.12 | 13.49 | 13.40 | -12.19 | 18.95 | 13.98 |
Aurobindo Pharma | 4.16 | 0.37 | -1.39 | -1.69 | -29.51 | 28.16 | 6.17 |
Glenmark Pharmaceuticals | -4.41 | 3.19 | 23.20 | 42.38 | 18.91 | 76.49 | 32.85 |
Anthem Biosciences | 5.89 | 7.84 | 18.23 | 18.23 | 18.23 | 5.74 | 3.41 |
Laurus Labs | -0.51 | 3.09 | 35.04 | 53.43 | 77.96 | 20.69 | 25.98 |
Biocon | -2.53 | -2.59 | 0.62 | 6.24 | -5.53 | 6.94 | -4.31 |
GlaxoSmithKline Pharmaceuticals | -3.46 | -1.94 | -15.89 | 1.60 | -2.30 | 24.69 | 9.19 |
Cohance Lifesciences | -2.30 | 7.56 | -2.57 | -14.86 | -16.33 | 28.11 | 20.30 |
Ipca Laboratories | -0.07 | -5.18 | -3.23 | -0.19 | -9.85 | 15.26 | 4.10 |
Gland Pharma | 4.39 | 0.78 | 13.75 | 27.92 | 7.57 | -3.99 | 1.77 |
Over the last one year, Vivanza Biosciences has declined 46.15% compared to peers like Sun Pharmaceutical Industries (-13.17%), Divi's Laboratories (11.03%), Cipla (-6.69%). From a 5 year perspective, Vivanza Biosciences has underperformed peers relative to Sun Pharmaceutical Industries (25.92%) and Divi's Laboratories (13.53%).
Day | SMA | EMA |
---|---|---|
5 | 2.06 | 2.08 |
10 | 2.06 | 2.07 |
20 | 2.07 | 2.07 |
50 | 2.08 | 2.1 |
100 | 2.19 | 2.23 |
200 | 2.53 | 2.77 |
In the latest quarter, Vivanza Biosciences remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding unchanged at 79.98% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
---|---|
Sep 04, 2025, 9:11 PM IST | Vivanza Biosciences - Reg. 34 (1) Annual Report. |
Sep 04, 2025, 12:26 AM IST | Vivanza Biosciences - Annual Report |
Sep 04, 2025, 12:18 AM IST | Vivanza Biosciences - Shareholding Meeting - 43Rd Annual General Meeting (AGM) On Thursday, September 25, 2025 |
Sep 01, 2025, 9:29 PM IST | Vivanza Biosciences - Board Meeting Outcome for Outcome Of Board Meeting Held On Monday September 01, 2025 Related To 43Rd An |
Aug 30, 2025, 7:01 PM IST | Vivanza Biosciences - Announcement under Regulation 30 (LODR)-Change in Management |
Vivanza Biosciences Ltd. is a Public Limited Listed company incorporated on 06/03/1982 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24110GJ1982PLC005057 and registration number is 005057. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 2.94 Cr. and Equity Capital is Rs. 4.00 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Vivanza Biosciences is ₹2.10 as on Sep 17, 2025.
The Vivanza Biosciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Vivanza Biosciences is ₹8.40 Cr as on Sep 17, 2025.
Today’s highest and lowest price of Vivanza Biosciences are ₹2.22 and ₹2.07.
The 52-week high/low is the highest and lowest price at which Vivanza Biosciences stock has traded in the past 52-week or nearly a year. The 52-week high of Vivanza Biosciences is ₹4.36 and 52-week low of Vivanza Biosciences is ₹1.90 as on Sep 17, 2025.
The Vivanza Biosciences has shown returns of -0.94% over the past day, 0.96% for the past month, -7.08% over 3 months, -46.15% over 1 year, -47.76% across 3 years, and 2.76% over 5 years.
P/E ratio of and PB ratio of Vivanza Biosciences are -9.86 and 1.71 on Sep 17, 2025. While the company gives a dividend yield of 0.00 per annum.